Quantitative Radiology Solutions
About Quantitative Radiology Solutions
Quantitative Radiology Solutions, which later operated as Quantaras, was a healthcare AI company focused on developing software for advanced body-wide analysis of medical images. Their primary product, Automatic Anatomy Recognition (AAR) software, was designed to recognize, delineate, and identify anatomical objects and diseased tissue on MRI, CT, and PET/CT images. This technology aimed to personalize cancer treatment decisions, particularly by significantly reducing the time required for radiation treatment planning and improving the accuracy and consistency of organ-at-risk contouring, thereby helping to reduce side effects for cancer patients undergoing radiation therapy. The company received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its AAR technology for use in radiation treatment planning in April 2021. However, according to PitchBook, the company is now out of business as of February 2, 2025.
Focus Areas
Business Intelligence
| Key Investors | Phase 1 Ventures, Ben Franklin Technology Partners, National Cancer Institute (STTR grants), National Science Foundation (STTR grants) |
| Partnerships | University of Pennsylvania, University of Maryland, Rutgers University, Washington University in St. Louis (clinical evaluation sites), New York Proton Center |
| Technology | Software-only medical device, cloud-based platform, Automatic Anatomy Recognition (AAR) technology, fuzzy anatomy models, hierarchical image analysis, works with MRI, CT, and PET/CT images |
| FDA Clearances | 1 cleared products (estimated) |
What Physicians Need to Know
For physicians, Quantitative Radiology Solutions offers a significant leap in efficiency and precision for radiation treatment planning. The Automatic Anatomy Recognition (AAR) software can reduce the time spent on manual organ contouring from hours to minutes, freeing up valuable physician and dosimetrist time. This speed, combined with improved accuracy and consistency in OAR delineation, directly contributes to more precise and personalized radiation therapy, potentially leading to better patient outcomes and reduced side effects. The cloud-based, system-agnostic nature of AAR means it can be readily integrated into existing workflows, providing objective and quantitative data to inform critical treatment decisions and facilitate adaptive replanning.
Quantitative Radiology Solutions' AAR is a software-only medical device deployed on a cloud-based platform. It is designed to work independently of a specific treatment planning system and produces contours for direct input into these systems. The FDA 510(k) clearance specifies that AAR relies on third-party treatment planning systems to display and edit the generated contours.
Reviews & Opinions
Videos
News, demos, and interviews about Quantitative Radiology Solutions.
Videos load interactively. If none appear, search YouTube for Quantitative Radiology Solutions →
Press & Coverage
Frequently Asked Questions
Related Companies
CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]
Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]
OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]
Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]
MedTalk AI is an Australian-based healthcare AI company focused on streamlining clinical documentation for physicians and other healthcare professionals. The company’s flagship product is an ambient AI medical scribe that listens to real clinical conversations and converts them into structured, accurate notes in real-time. This technology aims to free clinicians from the burden of manual […]
allergoSMART is a healthcare AI company that offers the world’s first AI-based complete solution for personalized mite allergen avoidance. The company’s system, allergoSMART, provides a unique AI digital solution for individuals with dust mite allergies, combining targeted prevention and treatment through comprehensive home environment optimization. [3] It integrates symptom tracking, telemedicine, and air purification into […]